However, the Eli Lilly lawsuit filed in April 2025 alleges marketing practices similar to those cited in the FDA warning letters: referencing branded drug clinical trials and selling tirzepatide in unapproved oral formats
The authors found no significant differences in expression levels of the inflammatory mediators Il-6 and Tnf- in WAT of Dapagliflozin-treated mice
If you are curious to uncover the exciting truth behind Semaglutides newfound popularity or have questions about its effectiveness, you have come to the right place
The growing emphasis on health awareness and increased insurance coverage have driven patient accessibility
Nutr Rep Int
Burke e colleghi, in una revisione delle implicazioni dermatologiche dei GLP-1 AR pubblicata nel 2025, sottolineano che la cute un organo con elevata espressione di recettori GLP-1 e GIP, e che gli effetti cutanei di questi farmaci non solo la disestesia, ma anche alterazioni delle ghiandole sebacee e delle unit pilosebacee meritano unattenzione sistematica che finora mancata (Burke et al., 2025)
